ArticleFrontiers in oncology2026
Construction and evaluation of machine learning models for postoperative prognosis prediction of biliary tract malignancies.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to construct a new machine learning model based on multiple risk factors to predict the prognosis of patients with biliary tract malignancies after surgery. Materials and methods: This study included 6,951 patients in the SEER database from 2004 to 2015, and 245 patients in our medical center from 2015 to 2022. The patients in the SEER database were divided into a training set and a test set in a 7:3 ratio. The data from this research center serves as the external validation set. The clinical outcome was overall survival (OS). Univariate and multivariate Cox regression analyses were used in the training set to screen out independent prognostic factors. Then, multiple machine learning models were constructed to predict the survival rates of patients at 1 year, 3 years and 5 years. The performance of the model was evaluated using the area under the curve (AUC), calibration curves, and the decision curve analysis (DCA). SHAP analysis was used to identify features with greater contributions to model prediction. Subgroup analysis and survival curves were used to evaluate the benefits of chemotherapy for patients with positive lymph nodes. Results: Age, sex, marital status, tumor site, tumor differentiation, AJCC stage, regional nodes examined, regional nodes positive, and LN surgery Scope were all independent risk factors affecting the OS of patients with biliary tract malignancies. Among the various models constructed, the random forest (RF) model showed good AUC values across different datasets. Moreover, the calibration curves and decision curve analysis of the RF model in different sets indicate that it has excellent performance. SHAP analysis indicates regional nodes positive, AJCC stage, tumor site, and age play a crucial role in the survival analysis of biliary tract malignancies. Chemotherapy was associated with improved OS among patients with positive lymph nodes in the training and test cohorts. Conclusions: This study developed a new machine learning model based on multiple risk factors, which can effectively predict the prognosis of patients with biliary tract malignancies after surgery. This model may assist postoperative risk stratification and individualized adjuvant treatment decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.